Clearside Biomedical Ownership | Who Owns Clearside Biomedical?


OverviewForecastRevenueFinancialsChartTranscripts

Clearside Biomedical Ownership Summary


Clearside Biomedical is owned by 11.68% institutional investors, 7.28% insiders, and 81.04% retail investors. Vanguard group is the largest institutional shareholder, holding 3.75% of CLSD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.60% of its assets in Clearside Biomedical shares.

CLSD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockClearside Biomedical11.68%7.28%81.04%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group2.81M3.75%$2.67M
Carmignac gestion1.93M2.59%$1.84M
Blackrock funding, inc. /de877.65K1.17%$833.76K
Blackrock798.14K1.14%$1.04M
Geode capital management764.06K1.02%$726.02K
Renaissance721.79K0.97%$685.70K
First manhattan co. llc.405.67K0.54%$385.38K
State street265.26K0.35%$252.00K
Bridgeway capital management255.00K0.34%$242.25K
Morgan stanley145.99K0.21%$189.79K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Brown wealth management100.00K0.03%$95.00K
Carmignac gestion1.93M0.03%$1.84M
Newman dignan & sheerar30.12K0.01%$28.62K
Bridgeway capital management255.00K0.01%$242.25K
Malaga cove capital10.00K0.00%$9.50K
Northeast financial consultants93.00K0.00%$88.35K
Two sigma securities21.20K0.00%$20.14K
First manhattan co. llc.405.67K0.00%$385.38K
Rockwood wealth management10.00K0.00%$9.95K
Renaissance721.79K0.00%$685.70K

Top Buyers

HolderShares% AssetsChange
Ubs group145.12K-145.12K
Blackrock funding, inc. /de877.65K-73.69K
State street265.26K-60.10K
Blackrock798.14K-39.91K
Susquehanna group, llp59.04K-38.72K

Top Sellers

HolderShares% AssetsChange
Armistice capital---2.14M
First manhattan co. llc.405.67K0.00%-260.47K
Gcm grosvenor---198.69K
Castleview partners---161.96K
Rosalind advisors---127.22K

New Positions

HolderShares% AssetsChangeValue
Ubs group145.12K-145.12K$137.86K
Oppenheimer14.34K0.00%14.34K$13.62K
Virtu financial13.51K0.00%13.51K$13.00K
Malaga cove capital10.00K0.00%10.00K$9.50K
Royal bank of canada568.00-568.00$1.00K

Sold Out

HolderChange
Qube research-4.00
Householder group estate & retirement specialist-385.00
Jones financial companies lllp-1.00K
Golden state equity partners-3.40K
Simplex trading-4.42K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202441-22.64%8,729,652-13.15%116.46%17-15.00%7-41.67%
Sep 30, 2024533.92%10,051,240-27.00%133.46%2017.65%12-29.41%
Jun 30, 202451-7.27%13,768,135-11.32%193.12%17-45.16%17183.33%
Mar 31, 20245512.24%15,525,337100.43%2516.09%3193.75%6-45.45%
Dec 31, 202349-2.00%7,745,921-1.18%127.73%1633.33%11-26.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.97M2.60%-
Vanguard US Total Market Shares ETF1.97M2.55%-
Carmignac Pf L-S Eurp Eqs F EUR Acc1.51M1.96%-
Vanguard Institutional Extnd Mkt Idx Tr783.85K1.03%-
Fidelity Extended Market Index376.76K0.49%-2.40K
Carmignac Absolute Ret Eur A EUR Acc321.32K0.42%-103.87K
Bridgeway Ultra-Small Company Market255.00K0.34%-
iShares Micro-Cap ETF161.73K0.21%-
Fidelity Total Market Index139.56K0.18%-111.00
BlackRock Extended Equity Market K126.61K0.17%-54.00

Recent Insider Transactions


DateNameRoleActivityValue
Feb 24, 2025Thorp Clay-Buy$13.80K
Nov 01, 2024Chong Ngai Hang Victor Chief Medical OfficerBuy$36.50K
Jun 24, 2024Chong Ngai Hang Victor Chief Medical OfficerBuy$24.91K
May 15, 2024YERXA BENJAMIN R-Buy$10.24K
Apr 17, 2024Gibney Anthony S-Buy$8.39K

Insider Transactions Trends


DateBuySell
2025 Q11-
2024 Q41-
2024 Q24-
2024 Q132
2023 Q44-

CLSD Ownership FAQ


Who Owns Clearside Biomedical?

Clearside Biomedical shareholders are primarily institutional investors at 11.68%, followed by 7.28% insiders and 81.04% retail investors. The average institutional ownership in Clearside Biomedical's industry, Biotech Stocks , is 68.48%, which Clearside Biomedical falls below.

Who owns the most shares of Clearside Biomedical?

Clearside Biomedical’s largest shareholders are Vanguard group (2.81M shares, 3.75%), Carmignac gestion (1.93M shares, 2.59%), and Blackrock funding, inc. /de (877.65K shares, 1.17%). Together, they hold 7.52% of Clearside Biomedical’s total shares outstanding.

Does Blackrock own Clearside Biomedical?

Yes, BlackRock owns 1.14% of Clearside Biomedical, totaling 798.14K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.04M$. In the last quarter, BlackRock increased its holdings by 39.91K shares, a 5.26% change.

Who is Clearside Biomedical’s biggest shareholder by percentage of total assets invested?

Brown wealth management is Clearside Biomedical’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 100K Clearside Biomedical shares, valued at 95K$.

Who is the top mutual fund holder of Clearside Biomedical shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Clearside Biomedical shares, with 2.60% of its total shares outstanding invested in 1.97M Clearside Biomedical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools